We have located links that may give you full text access.
A Herpes Simplex virus 1 DNA Polymerase Multidrug Resistance Mutation Identified in an Immunocompromised Patient - Confirmed by Gene Editing.
Journal of Infectious Diseases 2023 May 25
BACKGROUND: Herpes simplex virus-1 (HSV-1) can cause severe infections in immunocompromised individuals. In these patients, emergence of drug-resistance mutations causes difficulties in the infection management.
METHODS: Seventeen HSV-1 isolates were obtained from orofacial and anogenital lesions in a leaky severe combined immunodeficiency (SCID) patient over 7-years' time before and after stem cell transplantation. Spatial and temporal evolution of drug-resistance was characterized genotypically [Sanger sequencing and next-generation sequencing (NGS) of viral thymidine kinase (TK) and DNA polymerase (DP)], and phenotypically. Clustered regularly interspaced short palindromic repeats(CRISPR)/Cas9 was used to introduce the novel DP-Q727R mutation and dual infection competition assays were performed to assess viral fitness.
RESULTS: All isolates had identical genetic background suggesting that orofacial and anogenital infections derived from the same virus lineage. Eleven isolates proved heterogeneous TK virus populations by NGS, undetectable by Sanger sequencing. Thirteen isolates were acyclovir-resistant due to TK mutations, and the Q727R isolate additionally exhibited foscarnet/adefovir-resistance. Recombinant Q727R-mutant virus showed multidrug-resistance and increased fitness under antiviral pressure.
CONCLUSIONS: Long-term follow-up of a SCID patient revealed virus evolution and frequent reactivation of wild-type and TK-mutant strains, mostly as heterogeneous populations. The DP-Q727R resistance phenotype was confirmed using CRISPR/Cas9, a useful tool to validate novel drug-resistance mutations.
METHODS: Seventeen HSV-1 isolates were obtained from orofacial and anogenital lesions in a leaky severe combined immunodeficiency (SCID) patient over 7-years' time before and after stem cell transplantation. Spatial and temporal evolution of drug-resistance was characterized genotypically [Sanger sequencing and next-generation sequencing (NGS) of viral thymidine kinase (TK) and DNA polymerase (DP)], and phenotypically. Clustered regularly interspaced short palindromic repeats(CRISPR)/Cas9 was used to introduce the novel DP-Q727R mutation and dual infection competition assays were performed to assess viral fitness.
RESULTS: All isolates had identical genetic background suggesting that orofacial and anogenital infections derived from the same virus lineage. Eleven isolates proved heterogeneous TK virus populations by NGS, undetectable by Sanger sequencing. Thirteen isolates were acyclovir-resistant due to TK mutations, and the Q727R isolate additionally exhibited foscarnet/adefovir-resistance. Recombinant Q727R-mutant virus showed multidrug-resistance and increased fitness under antiviral pressure.
CONCLUSIONS: Long-term follow-up of a SCID patient revealed virus evolution and frequent reactivation of wild-type and TK-mutant strains, mostly as heterogeneous populations. The DP-Q727R resistance phenotype was confirmed using CRISPR/Cas9, a useful tool to validate novel drug-resistance mutations.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app